Nils Siegbahn
Director/Board Member bei GLYCOREX TRANSPLANTATION AB
Profil
Nils Siegbahn is currently a Director at Glycorex Transplantation AB and a Director at Sparbanksstiftelsen Skånes Riskkapitalstiftelse.
He was previously the Chief Executive Officer at Pernovo AB, Chairman at Glycorex Transplantation AB, Managing Director at Niconovum AB, President at Alligator Bioscience AB, Director-Special Projects at Perstorp Holding AB, Director at Atos Medical AB, Director at Celltrix AB, and Independent Director at Enzymatica AB.
Dr. Siegbahn holds a graduate degree from Stockholm School of Economics and a doctorate degree from the Faculty of Engineering, Lund University.
Aktive Positionen von Nils Siegbahn
| Unternehmen | Position | Beginn |
|---|---|---|
| GLYCOREX TRANSPLANTATION AB | Director/Board Member | 01.01.2021 |
Sparbanksstiftelsen Skånes Riskkapitalstiftelse
 Sparbanksstiftelsen Skånes Riskkapitalstiftelse Financial ConglomeratesFinance Sparbanksstiftelsen Skånes Riskkapitalstiftelse invests in high-risk projects. The firm seeks to invest in the form of share acquisitions, possibly combined with shareholder's contributions or convertible loans and the investment can be initial, as well as a follow-on investment. The company was founded in 2007 and is headquartered in Malmo, Sweden. | Director/Board Member | - |
Ehemalige bekannte Positionen von Nils Siegbahn
| Unternehmen | Position | Ende |
|---|---|---|
| ENZYMATICA AB | Director/Board Member | 19.12.2016 |
| GLYCOREX TRANSPLANTATION AB | Chairman | 01.01.2009 |
| ALLIGATOR BIOSCIENCE AB | President | 01.07.2004 |
Perstorp Holding AB
 Perstorp Holding AB Chemicals: Major DiversifiedProcess Industries Perstorp Holding AB engages in the development, manufacture and sale of specialty chemicals. It operates through the Specialties and Solutions, and Advanced Chemicals and Derivatives segments. The Specialties and Solutions segment consists of the business units, Feed and Food, and Specialty Polyols. The Advanced Chemicals and Derivatives segment includes the business units Penta, Oxo, TMP and Neo, and Formates. The company was founded by Wilhelm Wendt in 1881 and is headquartered in Malmo, Sweden. | Corporate Officer/Principal | - |
Atos Medical AB
 Atos Medical AB Medical SpecialtiesHealth Technology Atos Medical AB engages in the development and manufacture of medical products for the ear, nose, and throat areas. The firm provides solutions to people who breathe through a stoma. It offers a range of voice- and pulmonary rehabilitation devices, and provox products. The company was founded by Gert Persson and Jan-Ove Persson in 1986 and is headquartered in Malmo, Sweden. | Director/Board Member | - |
Ausbildung von Nils Siegbahn
| Stockholm School of Economics | Graduate Degree |
| Faculty of Engineering, Lund University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| GLYCOREX TRANSPLANTATION AB | Health Technology |
| ALLIGATOR BIOSCIENCE AB | Health Technology |
| ENZYMATICA AB | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Atos Medical AB
Atos Medical AB Medical SpecialtiesHealth Technology Atos Medical AB engages in the development and manufacture of medical products for the ear, nose, and throat areas. The firm provides solutions to people who breathe through a stoma. It offers a range of voice- and pulmonary rehabilitation devices, and provox products. The company was founded by Gert Persson and Jan-Ove Persson in 1986 and is headquartered in Malmo, Sweden. | Health Technology |
Perstorp Holding AB
Perstorp Holding AB Chemicals: Major DiversifiedProcess Industries Perstorp Holding AB engages in the development, manufacture and sale of specialty chemicals. It operates through the Specialties and Solutions, and Advanced Chemicals and Derivatives segments. The Specialties and Solutions segment consists of the business units, Feed and Food, and Specialty Polyols. The Advanced Chemicals and Derivatives segment includes the business units Penta, Oxo, TMP and Neo, and Formates. The company was founded by Wilhelm Wendt in 1881 and is headquartered in Malmo, Sweden. | Process Industries |
| Pernovo AB | |
Celltrix AB
 Celltrix AB Medical SpecialtiesHealth Technology Celltrix AB manufactures medical devices. It develops novel and injectable dermal filler for reconstructive cosmetic surgery, based on microbeads of cross-linked gelatine. The company was founded in December 2003 by Kjell Gösta Conny Nilsson and is headquartered in Malmö, Sweden. | Health Technology |
Niconovum AB
 Niconovum AB Miscellaneous Commercial ServicesCommercial Services Niconovum AB conducts research and development for nicotine replacement and produces medication for nicotine dependence therapy. The firm’s products include Zonnic Mouth Spray and Zonnic Pouch. The company was founded by Karl Olov Fagerström in 2000 and is headquartered in Helsingborg, Sweden. | Commercial Services |
Sparbanksstiftelsen Skånes Riskkapitalstiftelse
Sparbanksstiftelsen Skånes Riskkapitalstiftelse Financial ConglomeratesFinance Sparbanksstiftelsen Skånes Riskkapitalstiftelse invests in high-risk projects. The firm seeks to invest in the form of share acquisitions, possibly combined with shareholder's contributions or convertible loans and the investment can be initial, as well as a follow-on investment. The company was founded in 2007 and is headquartered in Malmo, Sweden. | Finance |
